Comparison of starting ovarian stimulation on day 2 versus day 15 of the menstrual cycle in the same oocyte donor and pregnancy rates among the corresponding.

Slides:

Advertisements

Similar presentations

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis

Advertisements

Krinos M. Trokoudes, M. D. , Constantinos Pavlides, M. Sc

What is a difficult transfer

A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome? Ronit Machtinger, M.D., Joseph.

Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment Javier Domingo, M.D., Vicente.

Soyoung Bae, M.D., Joseph Karnitis, M.D. Fertility and Sterility

Risks of tubo-ovarian abscess in cases of endometrioma and assisted reproductive technologies are both under- and overreported Claire Villette, M.D.,

Akanksha Mehta, M.D., Mark Sigman, M.D. Fertility and Sterility

Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.

Outdoor air pollution and sperm quality

Patient and cycle characteristics predicting high pregnancy rates with single-embryo transfer: an analysis of the Society for Assisted Reproductive Technology.

Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective,

The normal variabilities of the menstrual cycle

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor.

Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase Michael von Wolff, M.D., Christian J. Thaler,

Michael M. Alper, M.D. Fertility and Sterility

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.

Impact of circulating levels of total and bioavailable serum vitamin D on pregnancy rate in egg donation recipients Alberta Fabris, M.D., Alberto Pacheco,

Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials Ana Cobo, Ph.D., César Diaz, M.D.

Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day.

Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles Angela R. Baerwald, Ph.D.,

Cem Atabekoglu, M. D. , Murat Sonmezer, M. D. , Sinan Özkavukcu, M. D

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study Nicole Hope, M.B., B.S., Hon., Luk.

Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study Leonidas Mamas, M.D., Ph.D.

What is the quality of information on social oocyte cryopreservation provided by websites of Society for Assisted Reproductive Technology member fertility.

Inmaculada Molina, Ph. D. , Juan V. Martínez, M. S. , José F

Medical treatment of ectopic pregnancy: a committee opinion

Konstantinos Pantos, M. D. , Evangelos Makrakis, M. D

Live birth of twins derived from zona-free oocytes

Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers Andrea.

A comparison of blood spot vs

Triploidy formation after intracytoplasmic sperm injection may be a surrogate marker for implantation Mitchell P. Rosen, M.D., Shehua Shen, M.D., Anthony.

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Oocyte cryopreservation

Transvaginal versus transabdominal ultrasound guidance for embryo transfer in donor oocyte recipients: a randomized clinical trial Daniel Bodri, M.D.,

Lena Dain, M. D. , David Bider, M. D. , Jacob Levron, M. D

Looking back: egg donors' retrospective evaluations of their motivations, expectations, and experiences during their first donation cycle Nancy J. Kenney,

Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study Ahmet Erdem, M.D., Mehmet Erdem,

Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer Caroline Smith, Ph.D., Meaghan Coyle, B.Hlth.Sc. (Acup.),

A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization Laura Detti, M.D., Daniel B. Williams, M.D., Jared.

A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis

Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,

Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles Karin.

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage,

Number of good quality embryos on day 3 is predictive for both pregnancy and implantation rates in in vitro fertilization/intracytoplasmic sperm injection.

Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis

Jennifer F. Kawwass, M. D. , Sara Crawford, Ph. D. , Donna R

Prospective cohort study of three- versus two-dimensional ultrasound for prediction of oocyte maturity Doron Shmorgun, M.D., Edward Hughes, M.D., Patrick.

Live babies born per oocyte retrieved in a subpopulation of oocyte donors with repetitive reproductive success J. Ryan Martin, M.D., Jason G. Bromer,

Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation Allison Styne-Gross, M.D., Karen.

Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing

Relaxin has a role in establishing a renal response in pregnancy

Fertility and Sterility: an evaluation

Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,

Association of endometriosis with body size and figure

Current evaluation of amenorrhea

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Diane De Neubourg, M. D. , Kathelijne Mangelschots, B. Sc

In vitro sildenafil citrate use as a sperm motility stimulant

Krinos M. Trokoudes, M. D. , Constantinos Pavlides, M. Sc

Infertility induced by cancer treatment: inappropriate or no information provided to majority of French survivors of cancer Julien Mancini, M.D., M.P.H.,

Briana J. Rudick, M. D. , Sue Ann Ingles, Ph. D. , Karine Chung, M. D

A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders Hakan Cakmak, M.D., Nam D. Tran,

Contact among families who share the same sperm donor

Comparisons of inhibin B versus antimüllerian hormone in poor ovarian responders undergoing in vitro fertilization Rongrong Tan, M.M.Sc., Danhua Pu,

Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment Daniel Bodri, M.D., M.Sc.,

Presentation transcript:

Comparison of starting ovarian stimulation on day 2 versus day 15 of the menstrual cycle in the same oocyte donor and pregnancy rates among the corresponding recipients of vitrified oocytes Francisca Martínez, Ph.D., Elisabet Clua, B.Sc., Marta Devesa, M.D., Ignacio Rodríguez, B.Sc., Gemma Arroyo, B.Sc., Clara González, B.Sc., Miquel Solé, B.Sc., Rosa Tur, Ph.D., Buenaventura Coroleu, Ph.D., Pedro N. Barri, Ph.D. Fertility and Sterility Volume 102, Issue 5, Pages 1307-1311 (November 2014) DOI: 10.1016/j.fertnstert.2014.07.741 Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Study flow chart. D2: donors stimulated from day 2. D15: donors stimulated from day 15. R-D2: Recipients of oocytes of donors stimulated from day 2. R-D15: Recipients of oocytes from donors stimulated from day 15. Fertility and Sterility 2014 102, 1307-1311DOI: (10.1016/j.fertnstert.2014.07.741) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions